61314-0866 ZIEXTENZO - CanMED: NDC

Product NDC:

61314-0866

Brand Name:

ZIEXTENZO

Generic Name:

Pegfilgrastim-bmez

Dosage Form Name:

INJECTION

Administration Route:

Subcutaneous

Substances:

Name: PEGFILGRASTIM

Strength: 6.0

Unit: mg/.6mL

Packages:

Code: 61314-0866-01

Description: 1 BLISTER PACK in 1 CARTON (61314-866-01) / 1 SYRINGE in 1 BLISTER PACK / .6 mL in 1 SYRINGE

Effective Date: Nov. 4, 2019

Discontinued: Feb. 28, 2026

Code: 61314-0866-02

Description: 1 BLISTER PACK in 1 CARTON (61314-866-02) / 1 SYRINGE in 1 BLISTER PACK / .6 mL in 1 SYRINGE

Effective Date: March 3, 2025

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Immunostimulant

Minor Class:

Colony-Stimulating Factor

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox